Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Lomefloxacin in Complicated UTI
NCT00258102Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 1993
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of levofloxacin in complicated urinary tract infection (cUTI) (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Clinical Response and Microbiological Response. Started Jan 1993; status: completed.
02
Drugs
levofloxacin
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT00258102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258102.